Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01479790
Other study ID # R845/40/2011
Secondary ID 2011/408/A
Status Completed
Phase N/A
First received October 4, 2011
Last updated February 20, 2013
Start date June 2011
Est. completion date December 2012

Study information

Verified date February 2013
Source Singapore National Eye Centre
Contact n/a
Is FDA regulated No
Health authority Singapore: Health Sciences Authority
Study type Interventional

Clinical Trial Summary

Dry eye is a common condition that affects vision and quality of life in patients. Dry eye clinical research is limited to follow up of disease progression. Currently, most research outcomes are based on subjective patient complaints rather than objective assessment of the condition. Only few objective measurements for dry eye are available today and this is mainly the result of poor repeatability and inaccuracy.

This current study aims to evaluate 2 new non-invasive imaging techniques suitable for dry eye assessment.

Anterior segment optical coherence tomography (AS-OCT) is an imaging device that has the ability to image the tear meniscus of the eye in a safe and non-invasive manner. Image analysis can then indirectly determine the tear film volume. Improvements in the image resolution of these devices require a study that compares the repeatability and agreement of an older (Visante AS-OCT) and a newer instrument (Cirrus AS-OCT) which the current study aims to address.

Another method of evaluating dry eye disease is a novel technique that uses functional infrared thermography to measure tear evaporation rate. This study will also establish repeatability of measurements of the ocular surface temperature which are used to calculate tear evaporation rates.

Should these methods are found to be repeatable, they can be used in future clinical trials as an additional tool to investigate dry eye treatments.


Description:

Study Objectives and Purpose:

Part A - AS-OCT repeatability and agreement

1. The primary purpose of Part A is to compare the repeatability of the Cirrus with the Visante AS-OCT imaging system.

2. The second objective is to identify the level of agreement in the tear meniscus measurements taken by the Cirrus and Visante AS-OCT.

Part B - Tear evaporimetry with functional infra-red thermography

1. To evaluate the repeatability of Infrared thermography for ocular surface temperature measurements that are used for calculation of tear evaporation rates. If this is found to be acceptable, it will be correlated to tear meniscus parameters.

2. To determine whether this method is able to detect temperature changes of the ocular surface.

Study design:

Part A. Cross sectional study. Part B. Prospective study

Rationale:

Part A - AS-OCT repeatability and agreement Repeatability is an important issue in the objective assessment of dry eye. While previous studies have compared various methods of measuring the tear meniscus, including the use of Visante AS-OCT, current literature lacks studies that investigated the Cirrus AS-OCT for assessment of dry eye. With a higher resolution, the Cirrus is potentially useful as a non-invasive procedure for objective measurements of the tear meniscus.

Part B - Tear evaporimetry with functional infra-red thermography Current available methods to measure of tear evaporation rate have major limitations. This new method, however, is non-invasive, has no need for special eye drops or chambers and takes temperature measurements very quickly. This method is therefore extremely practical and provides many exciting possibilities for future trials.

Methods:

Participants and target sample size 40 volunteers from Singapore Eye Research Institute will be recruited for this study. Each volunteer will be given a study serial number to ensure anonymity.

20 will participate in the AS-OCT study. 20 will participate in the tear evaporimetry study.

Part A - AS-OCT repeatability and agreement Two AS-OCT imaging systems, namely Cirrus and the Visante, will be tested. All participants undergo acquisition of 2 images by the Visante AS-OCT, then 2 images by the Cirrus AS-OCT. Both images will be acquired by the same technician.

Part B - Tear evaporimetry with functional infra-red thermography In total, four pairs of thermographic sequences on the ocluar surface temperature from volunteers will be taken.

1. The volunteer will be seated in front of the thermographic camera and on each eye on thermographic sequence will be captured.

2. After 20 minutes, a second pair of thermographic sequences will be captured.

3. An eye mask with a temperature of not more than 40 deg C (confirmed by thermometer) will be worn by the volunteer for 5 minutes.

4. A third pair of thermographic sequences will be captured immediately after mask removal.

5. A fourth pair of thermographic sequences will be captured 1 hour after mask removal.

Between sequence acquisitions, the volunteer is allowed to move freely in the room. The temperature and humidity of the room will be kept constant during measurements.

Visit schedules:

Only one examination per ASOCT instrument for Part A is required. For Part B, all thermography will be performed on the same day.

If participants agree to have both ASOCT and tear evaporimetry done, then they will undergo Parts A and B. If not, they will be recruited for either Part A or Part B.

Duration of study: 1 day


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years to 90 Years
Eligibility Inclusion Criteria:

- Volunteers that are medically fit and willing to participate in this study.

Exclusion Criteria:

- No eye surgery done within the previous 3 months

- Active ocular infection or pterygium that may affect tear film stability.

- Any other specified reason as determined by clinical investigator.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening


Related Conditions & MeSH terms


Intervention

Device:
EyeGiene
The eye mask with a temperature of not more than 40 deg C (confirmed by thermometer) will be worn by the volunteer for 5 minutes.

Locations

Country Name City State
Singapore Singapore Eye Research Institute Singapore

Sponsors (3)

Lead Sponsor Collaborator
Singapore National Eye Centre Nanchang University, Singapore Eye Research Institute

Country where clinical trial is conducted

Singapore, 

References & Publications (2)

Savini G, Goto E, Carbonelli M, Barboni P, Huang D. Agreement between stratus and visante optical coherence tomography systems in tear meniscus measurements. Cornea. 2009 Feb;28(2):148-51. doi: 10.1097/ICO.0b013e31818526d0. — View Citation

Tan JH, Ng EY, Acharya UR. Evaluation of tear evaporation from ocular surface by functional infrared thermography. Med Phys. 2010 Nov;37(11):6022-34. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary equipment repeatability Part A - The repeatabilty coefficients of tear meniscus measurements derived from Visante and Cirrus AS-OCT and the agreement between tear meniscus measurements.
Part B - Infrared thermography is expected to be repeatable in capturing OST measurements which will consequently result in repeatable tear evaporation rates. Temperature changes of the ocular surface will be adequately captured.
1 day No
Secondary temperature changes Determine whether thermogram images can capture changes in temperature/the rate of tear evaporation which were introduced by warm eye mask wear. 1 day No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Not yet recruiting NCT06379685 - Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. Phase 1
Recruiting NCT04701086 - 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis N/A
Active, not recruiting NCT03697876 - Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel Phase 1
Terminated NCT02815293 - Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye Phase 3
Completed NCT02910713 - Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation N/A
Completed NCT04104997 - A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers Phase 1
Recruiting NCT02595606 - 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients Phase 4
Completed NCT01711424 - An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease N/A
Completed NCT01015209 - Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers Phase 1
Completed NCT01202747 - Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction Phase 2/Phase 3
Completed NCT00969280 - Acupuncture for Dry Eye Syndrome Phase 3
Completed NCT00739713 - Effects of Sea Buckthorn Oil on Dry Eye N/A
Completed NCT01496482 - Comparison of Evaporimetry With the Established Methods of Tear Film Measurement N/A
Completed NCT00756678 - Efficacy and Acceptability of Two Lubricant Eye Drops Phase 4
Completed NCT00370747 - Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome Phase 2
Completed NCT00349440 - Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy Phase 4
Completed NCT05162261 - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction N/A
Completed NCT02871440 - A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye Phase 3
Completed NCT05042960 - Computer Screen Properties Study N/A